How RWE can support drug development during COVID-19 and beyond
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
Open claims and closed payer claims data are essential for understanding the status and activities of patients along their healthcare journey, but which data type is most useful and when? Whether the intent is to measure the cost effectiveness of a...
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
COVID-19 has heightened the need for an expanded understanding of clinical trial populations and...
The healthcare industry relies on real-world data more and more to make informed and effective...
December, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its...
November 24, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its...
Building a modern data infrastructure within today’s healthcare enterprise is challenging on many...
October 19, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its...
HealthVerity empowers fourteen team members to form the Equity, Inclusion and Diversity (EID)...
The “acceleration of digital health transformation” means many things to many people, but through...
“COVID-19 has impacted nearly every organization—from enterprise to startup—and their strategies...
In the rapidly evolving world of real-world data (RWD) for life sciences and commercial applications, data provenance and data quality serve as unwavering cornerstones for actionable insights. Yet, an unsettling trend has emerged in the form of "Zomb...